Tuberc Respir Dis > Volume 39(3); 1992 > Article
Tuberculosis and Respiratory Diseases 1992;39(3):209-218.
DOI: https://doi.org/10.4046/trd.1992.39.3.209    Published online June 1, 1992.
Immunotherapy of tuberculosis.
Dong Won Kwon
Korean Institute of Tuberculosis, Korean National Tuberculosis
Abstract
Despite the availability of drugs effective in producing a bacteriological cure, tuberculosis presents continuing problems in its control, especially in the developing world. An effective immunotherapy to be used with chemotherapy is urgently required. Intradermal injection of a suspension of killed Mycobacterium vaccae switches off the tissue.necrotizing component of the Koch phenomenon, and promotes cell.mediated responses to the common, putative protective, mycobacterial antigens. These properties led to the employment of the suspension in immunotherapy as an adjunct to chemotherapy in the treatment of both tuberculosis and leprosy. The evidence leading to these conclusions is reviewed.


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next